Correspondence 1: Cancer vaccines: pessimism in check
[Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwen...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Mocellin, Simone [verfasserIn] Mandruzzato, Susanna [verfasserIn] Bronte, Vincenzo [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
s.l.: Nature Publishing Group ; 2004 |
|---|
| Umfang: |
2 |
|---|
| Reproduktion: |
Nature Archives 1869 - 2009 |
|---|---|
| Übergeordnetes Werk: |
In: Nature medicine - New York, NY : Nature America Inc., 1995, 10(2004), 12 vom: Jan., Seite 1278-1279 |
| Übergeordnetes Werk: |
volume:10 ; year:2004 ; number:12 ; month:01 ; pages:1278-1279 ; extent:2 |
| Links: |
|---|
| DOI / URN: |
10.1038/nm1204-1278 |
|---|
| Katalog-ID: |
NLEJ23171677X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ23171677X | ||
| 003 | DE-627 | ||
| 005 | 20230506005530.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 110224s2004 xxu|||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/nm1204-1278 |2 doi | |
| 035 | |a (DE-627)NLEJ23171677X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 044 | |c XD-US | ||
| 100 | 1 | |a Mocellin, Simone |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correspondence 1: Cancer vaccines: pessimism in check |
| 264 | 1 | |a [s.l.] |b Nature Publishing Group |c 2004 | |
| 300 | |a 2 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a [Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ... | ||
| 533 | |f Nature Archives 1869 - 2009 | ||
| 700 | 1 | |a Mandruzzato, Susanna |e verfasserin |4 aut | |
| 700 | 1 | |a Bronte, Vincenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Marincola, Francesco M |4 oth | |
| 773 | 0 | 8 | |i In |t Nature medicine |d New York, NY : Nature America Inc., 1995 |g 10(2004), 12 vom: Jan., Seite 1278-1279 |w (DE-627)NLEJ22768236X |w (DE-600)1484517-9 |x 1546-170X |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2004 |g number:12 |g month:01 |g pages:1278-1279 |g extent:2 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/nm1204-1278 |q application/pdf |z Deutschlandweit zugänglich |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-NTA | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2004 |e 12 |c 1 |h 1278-1279 |g 2 | ||
| author_variant |
s m sm s m sm v b vb |
|---|---|
| matchkey_str |
article:1546170X:2004----::orsodnecnevcieps |
| hierarchy_sort_str |
2004 |
| publishDate |
2004 |
| allfields |
10.1038/nm1204-1278 doi (DE-627)NLEJ23171677X DE-627 ger DE-627 rakwb eng XD-US Mocellin, Simone verfasserin aut Correspondence 1: Cancer vaccines: pessimism in check [s.l.] Nature Publishing Group 2004 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ... Nature Archives 1869 - 2009 Mandruzzato, Susanna verfasserin aut Bronte, Vincenzo verfasserin aut Marincola, Francesco M oth In Nature medicine New York, NY : Nature America Inc., 1995 10(2004), 12 vom: Jan., Seite 1278-1279 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:10 year:2004 number:12 month:01 pages:1278-1279 extent:2 http://dx.doi.org/10.1038/nm1204-1278 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 10 2004 12 1 1278-1279 2 |
| spelling |
10.1038/nm1204-1278 doi (DE-627)NLEJ23171677X DE-627 ger DE-627 rakwb eng XD-US Mocellin, Simone verfasserin aut Correspondence 1: Cancer vaccines: pessimism in check [s.l.] Nature Publishing Group 2004 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ... Nature Archives 1869 - 2009 Mandruzzato, Susanna verfasserin aut Bronte, Vincenzo verfasserin aut Marincola, Francesco M oth In Nature medicine New York, NY : Nature America Inc., 1995 10(2004), 12 vom: Jan., Seite 1278-1279 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:10 year:2004 number:12 month:01 pages:1278-1279 extent:2 http://dx.doi.org/10.1038/nm1204-1278 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 10 2004 12 1 1278-1279 2 |
| allfields_unstemmed |
10.1038/nm1204-1278 doi (DE-627)NLEJ23171677X DE-627 ger DE-627 rakwb eng XD-US Mocellin, Simone verfasserin aut Correspondence 1: Cancer vaccines: pessimism in check [s.l.] Nature Publishing Group 2004 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ... Nature Archives 1869 - 2009 Mandruzzato, Susanna verfasserin aut Bronte, Vincenzo verfasserin aut Marincola, Francesco M oth In Nature medicine New York, NY : Nature America Inc., 1995 10(2004), 12 vom: Jan., Seite 1278-1279 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:10 year:2004 number:12 month:01 pages:1278-1279 extent:2 http://dx.doi.org/10.1038/nm1204-1278 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 10 2004 12 1 1278-1279 2 |
| allfieldsGer |
10.1038/nm1204-1278 doi (DE-627)NLEJ23171677X DE-627 ger DE-627 rakwb eng XD-US Mocellin, Simone verfasserin aut Correspondence 1: Cancer vaccines: pessimism in check [s.l.] Nature Publishing Group 2004 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ... Nature Archives 1869 - 2009 Mandruzzato, Susanna verfasserin aut Bronte, Vincenzo verfasserin aut Marincola, Francesco M oth In Nature medicine New York, NY : Nature America Inc., 1995 10(2004), 12 vom: Jan., Seite 1278-1279 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:10 year:2004 number:12 month:01 pages:1278-1279 extent:2 http://dx.doi.org/10.1038/nm1204-1278 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 10 2004 12 1 1278-1279 2 |
| allfieldsSound |
10.1038/nm1204-1278 doi (DE-627)NLEJ23171677X DE-627 ger DE-627 rakwb eng XD-US Mocellin, Simone verfasserin aut Correspondence 1: Cancer vaccines: pessimism in check [s.l.] Nature Publishing Group 2004 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ... Nature Archives 1869 - 2009 Mandruzzato, Susanna verfasserin aut Bronte, Vincenzo verfasserin aut Marincola, Francesco M oth In Nature medicine New York, NY : Nature America Inc., 1995 10(2004), 12 vom: Jan., Seite 1278-1279 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:10 year:2004 number:12 month:01 pages:1278-1279 extent:2 http://dx.doi.org/10.1038/nm1204-1278 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 10 2004 12 1 1278-1279 2 |
| language |
English |
| source |
In Nature medicine 10(2004), 12 vom: Jan., Seite 1278-1279 volume:10 year:2004 number:12 month:01 pages:1278-1279 extent:2 |
| sourceStr |
In Nature medicine 10(2004), 12 vom: Jan., Seite 1278-1279 volume:10 year:2004 number:12 month:01 pages:1278-1279 extent:2 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
Nature medicine |
| authorswithroles_txt_mv |
Mocellin, Simone @@aut@@ Mandruzzato, Susanna @@aut@@ Bronte, Vincenzo @@aut@@ Marincola, Francesco M @@oth@@ |
| publishDateDaySort_date |
2004-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ22768236X |
| id |
NLEJ23171677X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ23171677X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506005530.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">110224s2004 xxu|||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1038/nm1204-1278</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ23171677X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="c">XD-US</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mocellin, Simone</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Correspondence 1: Cancer vaccines: pessimism in check</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[s.l.]</subfield><subfield code="b">Nature Publishing Group</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">[Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ...</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Nature Archives 1869 - 2009</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mandruzzato, Susanna</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bronte, Vincenzo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marincola, Francesco M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nature medicine</subfield><subfield code="d">New York, NY : Nature America Inc., 1995</subfield><subfield code="g">10(2004), 12 vom: Jan., Seite 1278-1279</subfield><subfield code="w">(DE-627)NLEJ22768236X</subfield><subfield code="w">(DE-600)1484517-9</subfield><subfield code="x">1546-170X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:12</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:1278-1279</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1038/nm1204-1278</subfield><subfield code="q">application/pdf</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-NTA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2004</subfield><subfield code="e">12</subfield><subfield code="c">1</subfield><subfield code="h">1278-1279</subfield><subfield code="g">2</subfield></datafield></record></collection>
|
| series2 |
Nature Archives 1869 - 2009 |
| author |
Mocellin, Simone |
| spellingShingle |
Mocellin, Simone Correspondence 1: Cancer vaccines: pessimism in check |
| authorStr |
Mocellin, Simone |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ22768236X |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
NL |
| publishPlace |
[s.l.] |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1546-170X |
| topic_title |
Correspondence 1: Cancer vaccines: pessimism in check |
| publisher |
Nature Publishing Group |
| publisherStr |
Nature Publishing Group |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
f m m fm fmm |
| hierarchy_parent_title |
Nature medicine |
| hierarchy_parent_id |
NLEJ22768236X |
| hierarchy_top_title |
Nature medicine |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ22768236X (DE-600)1484517-9 |
| title |
Correspondence 1: Cancer vaccines: pessimism in check |
| ctrlnum |
(DE-627)NLEJ23171677X |
| title_full |
Correspondence 1: Cancer vaccines: pessimism in check |
| author_sort |
Mocellin, Simone |
| journal |
Nature medicine |
| journalStr |
Nature medicine |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2004 |
| contenttype_str_mv |
zzz |
| container_start_page |
1278 |
| author_browse |
Mocellin, Simone Mandruzzato, Susanna Bronte, Vincenzo |
| container_volume |
10 |
| physical |
2 |
| format_se |
Elektronische Aufsätze |
| countryofpublication_str_mv |
XD-US |
| author-letter |
Mocellin, Simone |
| doi_str_mv |
10.1038/nm1204-1278 |
| author2-role |
verfasserin |
| title_sort |
correspondence 1: cancer vaccines: pessimism in check |
| title_auth |
Correspondence 1: Cancer vaccines: pessimism in check |
| abstract |
[Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ... |
| abstractGer |
[Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ... |
| abstract_unstemmed |
[Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ... |
| collection_details |
GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE |
| container_issue |
12 |
| title_short |
Correspondence 1: Cancer vaccines: pessimism in check |
| url |
http://dx.doi.org/10.1038/nm1204-1278 |
| remote_bool |
true |
| author2 |
Mandruzzato, Susanna Bronte, Vincenzo Marincola, Francesco M |
| author2Str |
Mandruzzato, Susanna Bronte, Vincenzo Marincola, Francesco M |
| ppnlink |
NLEJ22768236X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1038/nm1204-1278 |
| up_date |
2024-07-05T23:37:29.530Z |
| _version_ |
1803784184957763584 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ23171677X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506005530.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">110224s2004 xxu|||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1038/nm1204-1278</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ23171677X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="c">XD-US</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mocellin, Simone</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Correspondence 1: Cancer vaccines: pessimism in check</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[s.l.]</subfield><subfield code="b">Nature Publishing Group</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">[Auszug] To the editor: In the September issue of this journal, Rosenberg and colleagues published a turning-point article on the state of the art and future of cancer immunotherapy. The authors report a low tumor regression rate (2.6–3.3%) in patients (n = 1,205) with metastatic cancer who underwent ...</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Nature Archives 1869 - 2009</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mandruzzato, Susanna</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bronte, Vincenzo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marincola, Francesco M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nature medicine</subfield><subfield code="d">New York, NY : Nature America Inc., 1995</subfield><subfield code="g">10(2004), 12 vom: Jan., Seite 1278-1279</subfield><subfield code="w">(DE-627)NLEJ22768236X</subfield><subfield code="w">(DE-600)1484517-9</subfield><subfield code="x">1546-170X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:12</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:1278-1279</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1038/nm1204-1278</subfield><subfield code="q">application/pdf</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-NTA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2004</subfield><subfield code="e">12</subfield><subfield code="c">1</subfield><subfield code="h">1278-1279</subfield><subfield code="g">2</subfield></datafield></record></collection>
|
| score |
7.402439 |